Fromigué O - Search Results

1

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.

Habel N, Hamidouche Z, Girault I, Patiño-García A, Lecanda F, Marie PJ, Fromigué O. Habel N, et al. Among authors: fromigue o. Cell Death Dis. 2013 Oct 24;4(10):e874. doi: 10.1038/cddis.2013.405. Cell Death Dis. 2013. PMID: 24157868 Free PMC article.

2

Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.

Fromigué O, Hamidouche Z, Marie PJ. Fromigué O, et al. J Biol Chem. 2008 Nov 7;283(45):30549-56. doi: 10.1074/jbc.M801436200. Epub 2008 Aug 29. J Biol Chem. 2008. PMID: 18757369 Free PMC article.

3

RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.

Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ. Fromigué O, et al. Cell Death Differ. 2006 Nov;13(11):1845-56. doi: 10.1038/sj.cdd.4401873. Epub 2006 Feb 10. Cell Death Differ. 2006. PMID: 16470222

4

CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.

Fromigue O, Hamidouche Z, Vaudin P, Lecanda F, Patino A, Barbry P, Mari B, Marie PJ. Fromigue O, et al. J Bone Miner Res. 2011 Jul;26(7):1533-42. doi: 10.1002/jbmr.343. J Bone Miner Res. 2011. PMID: 21312266 Free article.

5

Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.

Sévère N, Dieudonné FX, Marty C, Modrowski D, Patiño-García A, Lecanda F, Fromigué O, Marie PJ. Sévère N, et al. Among authors: fromigue o. J Bone Miner Res. 2012 Oct;27(10):2108-17. doi: 10.1002/jbmr.1667. J Bone Miner Res. 2012. PMID: 22623369 Free article.

6

FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.

Brun J, Dieudonné FX, Marty C, Müller J, Schüle R, Patiño-García A, Lecanda F, Fromigué O, Marie PJ. Brun J, et al. Among authors: fromigue o. PLoS One. 2013;8(1):e55034. doi: 10.1371/journal.pone.0055034. Epub 2013 Jan 28. PLoS One. 2013. PMID: 23383046 Free PMC article.

7

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.

Habel N, Stefanovska B, Carène D, Patiño-Garcia A, Lecanda F, Fromigué O. Habel N, et al. Among authors: fromigue o. BMC Cancer. 2019 Jan 14;19(1):62. doi: 10.1186/s12885-019-5282-4. BMC Cancer. 2019. PMID: 30642298 Free PMC article.

8

Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.

Orosco A, Fromigué O, Bazille C, Entz-Werle N, Levillain P, Marie PJ, Modrowski D. Orosco A, et al. Among authors: fromigue o. Cancer Res. 2007 Apr 15;67(8):3708-15. doi: 10.1158/0008-5472.CAN-06-4164. Cancer Res. 2007. PMID: 17440083

9

Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs.

Fromigué O, Hamidouche Z, Marie PJ. Fromigué O, et al. J Pharmacol Exp Ther. 2008 May;325(2):595-600. doi: 10.1124/jpet.108.136127. Epub 2008 Feb 5. J Pharmacol Exp Ther. 2008. PMID: 18252811

10

Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells.

Hamidouche Z, Fromigué O, Nuber U, Vaudin P, Pages JC, Ebert R, Jakob F, Miraoui H, Marie PJ. Hamidouche Z, et al. Among authors: fromigue o. J Cell Physiol. 2010 Aug;224(2):509-15. doi: 10.1002/jcp.22152. J Cell Physiol. 2010. PMID: 20432451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters